Chief Financial Officer
Daniel M. Chism, has served as our Chief Financial Officer since June 7, 2024 and Vice President – Finance and Treasurer of its wholly owned subsidiary VTC, L.L.C. since June 7, 2024. Mr. Chism was previously the Chief Financial Officer at Goodwill Industries of Central Texas from 2020 to 2023, where he also served as a board member and Treasurer for two of Goodwill’s affiliates: Blue Solutions and Goodwill Temporary Services, Inc. Prior to 2020, Mr. Chism held Chief Financial Officer positions at EZCORP, Inc. (Nasdaq: EZPW), Cash Solutions Centers, and Gatsby Investments. Mr. Chism holds a master’s degree in professional accounting and a bachelor’s degree in accounting, each from the University of Texas at Austin. He is a certified public accountant and a chartered global management accountant.
On June 7, 2024, we entered into an employment agreement with Mr. Chism in connection with his appointment to Chief Financial Officer. Mr. Chism’s base salary was $325,000 for the year ended December 31, 2025, which, effective January 14, 2026, was increased to $350,000. Mr. Chism is eligible to receive a bonus in the amount and on the terms established by the Board of Directors. Mr. Chism is also entitled to receive vacation, health insurance and other benefits generally made available to our other executives. If we terminate Mr. Chism’s employment other than for “Cause” (as defined in the employment agreement) or Mr. Chism terminates his employment for a “Good Reason” (as defined in the employment agreement), we will continue paying Mr. Chism his base salary commencing on the date of termination and ending (a) six months from the date of termination, or (b) twelve months from the date of termination if the termination of employment is terminated within twelve months following a Change in Control (as defined in the employment agreement).
Chief Operating Officer
Mr. Marrott was hired as our Senior Vice President of Operations on November 2, 2022 and promoted to Chief Operating Officer effective July 1, 2024. Prior to joining us, from 2019 until 2022, Mr. Marrott was the Vice President – Operations for Applied Technical Services, a privately held full turnkey electronics manufacturer. Mr. Marrott has also held a number of executive level positions running business operations for companies including Flex, Solectron and Moduslink.
On November 2, 2022, we entered into an employment agreement with Mr. Marrott, and he was subsequently promoted to Chief Operating Officer effective July 1, 2024. Mr. Marrott’s base salary was $300,000 for the year ended December 31, 2025, which, effective January 14, 2026, was increased to $315,000. Mr. Marrott is entitled to receive vacation, health insurance, and other benefits generally made available to our other executives. If we terminate Mr. Marrott’s employment other than for “Cause” (as defined in the employment agreement) or Mr. Marrott terminates his employment for a “Good Reason” (as defined in the employment agreement), we will continue paying Mr. Marrott this base salary commencing on the date of termination and ending (a) six months from the date of termination, or (b) twelve months from the date of termination if the termination of employment is terminated within twelve months following a Change in Control (as defined in the employment agreement).
Director Compensation
We compensate each of our non-employee directors with an annual retainer of $40,000. The Chairman of our Board of Directors earns an additional annual retainer of $15,000, the Chairman of the Audit Committee earns an additional annual retainer of $10,000, and the Chairman of the Compensation Committee earns an additional annual retainer of $5,000.
In April 2017, we granted Mr. Woodward an option to purchase 200,000 shares of our common stock, which vested on the first anniversary of the date of grant. These options remained outstanding at December 31, 2025.
On October 11, 2024, upon his joining the Board of Directors, we granted Mr. Fahy an option to purchase 20,000 shares of our common stock, one third of which is scheduled to vest upon each of the first three anniversaries of the grant. At December 31, 2025, all of these options remained outstanding with 6,667 shares exercisable.
On November 11, 2025, upon his joining the Board of Directors, we granted Dr. Mohindra an option to purchase 6,000 shares of our common stock, one third of which is scheduled to vest on each of the first three anniversaries of the grant date. At December 31, 2025, all of these options remained outstanding, and none were exercisable.